During Market hours yesterday — (Monday – 15.03.2021):
- The Dow (Symbol: DIA) went up 0.5%. The S&P 500 (Symbol: SPY) rose 0.6% and the Nasdaq (Symbol: QQQ) popped 1.1%.
- Eli Lilly (Symbol: LLY) – Shares of the drugmaker fell by more than 9% after a phase two trial for donanemab showed that the treatment slowed the progression of Alzheimer’s disease. Mizuho Securities said in a note that the results were “solid, not stunning.”
- AMC Entertainment (Symbol: AMC) – Shares of the movie theater giant jumped 25.8% as it began reopening theaters in Los Angeles. AMC reopened two locations in the city on Monday, and plans to reopen the remaining 23 Los Angeles theaters by Friday. The company is hoping to have all of its locations across the state opened by Friday.
- American Airlines (Symbol: AAL), United Airlines (Symbol: UAL), Delta Air Lines (Symbol: DAL) and Alaska Air Group (Symbol: ALK) – Shares of the major U.S. airlines jumped on Monday amid optimism about a return to normal travel amid vaccine rollout. Air travel over the weekend hit its highest level in more than a year and airlines are seeing increased bookings. Shares of American Airlines and United Airlines rose by 7.7% and 8.3%, respectively. Delta popped 2.3% and Alaska Air Group gained 5.8%.
- MGM Resorts (Symbol: MGM) – The hotel and gaming stock rose about 5.1% after investment firm Jefferies upgraded MGM to buy from hold. The company cited an improving outlook for Las Vegas travel and the rise of online gambling as reasons for optimism.
- Unity Software (Symbol: U) – Shares of Unity Software popped 3.8% after Goldman Sachs started covering the video game stock with a buy rating, calling it “a design platform for the masses.” The Wall Street firm slapped a $126 per share price target on Unity, representing nearly 20% upside from its opening price of $105.70 per share.
- NXP Semiconductors (Symbol: NXPI), Penn National Gaming (Symbol: PENN) – S&P Dow Jones Indices announced new additions to the S&P 500 on Friday, boosting shares of Penn National Gaming and NXP Semiconductors. The stocks rose 9% and 4.6%, respectively, on Monday.
- GenMark Diagnostics (Symbol: GNMK) – Shares of the diagnostics company jumped 30% after an announcement that Roche was buying GenMark in an all-cash deal worth $1.8 billion. The potential for a deal had previously been reported.
During Premarket hours today – (Tuesday – 16.03.2021):
- AstraZeneca (Symbol: AZN) – AstraZeneca’s Covid-19 vaccine will be recommended for people aged 65 and older in Canada, according to a CBC report. That news comes after several European countries suspended use of the vaccine, amid reports of side effects. Both the World Health Organization and AstraZeneca say the vaccine is safe.
- Moderna (Symbol: MRNA) – The drugmaker began a study of its Covid-19 vaccine involving children aged 6 months to 11 years. Moderna’s vaccine – along with Johnson & Johnson’s (JNJ) – is currently authorized for adults 18 and older, while the vaccine from Pfizer (PFE) and BioNTech (BNTX) is allowed for people 16 and older.
- Designer Brands (Symbol: DBI) – The footwear and accessories retailer formerly known as DSW reported a quarterly loss of 53 cents per share, smaller than the 68 cents a share loss that analysts were anticipating. Revenue was below consensus, although comparable-store sales fell slightly less than expected. The company said the sequential improvement in performance continued during the quarter.
*Any information contained in this article, including any information contained in external third party links, if any, is solely for informational purposes and does not contain, or should not be construed as containing, investment advice or an investment recommendation, or, an offer of or solicitation for any transactions in financial instruments. Past performance does not guarantee or predict future performance. Colmex Pro Ltd does not take into account your personal investment objectives or financial situation and makes no representation, and assumes no liability to the accuracy or completeness of the information provided, nor for any loss arising from any investment based on presented information.